Moreover, extra-hepatic conditions (e.g., infection, tumors) involving inflammation also reduce the capacity of hepatic drug metabolism due to downregulation of hepatic CYP expression, probably mediated via inflammatory cytokines released by remotely inflamed organs, reaching the liver via systemic circulation [176,177]. This evidence concerns the gene PPIG and infection.